Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotec Pharmacon ASA

+ Add to Watchlist

BIOTEC:NO

15.700 NOK 0.200 1.26%

As of 10:25:26 ET on 02/27/2015.

Company Profile for Biotec Pharmacon ASA (BIOTEC)

Biotec Pharmacon ASA develops, manufactures and markets immune modulating compounds for the human and animal health sectors and marine enzymes used in molecular biology. The Company develops products to prevent or treat diseases caused by the failure, imbalance, and over-reaction of the immune system.

Contact Information

Biotec Pharmacon ASA

Sykehusveien 23
Tromso, 9019
Norway
Phone: 47-77-64-89-00
Fax: 47-77-64-89-01

Key Executives for Biotec Pharmacon ASA (BIOTEC)

Svein W F LienChief Executive OfficerArvid VangenCFO/CAO
Rolf EngstadCSO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil